MYR 0.08
(-6.25%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -1.88 Million MYR | 66.68% |
2022 | -5.66 Million MYR | -493.88% |
2021 | 1.43 Million MYR | 145.8% |
2020 | -3.13 Million MYR | -482648.15% |
2019 | -650.00 MYR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q2 | -82 Thousand MYR | -207.89% |
2023 Q1 | 76 Thousand MYR | 100.48% |
2023 Q4 | 223 Thousand MYR | 110.6% |
2023 Q3 | -2.1 Million MYR | -2465.85% |
2022 Q2 | 2.16 Million MYR | 66.92% |
2022 Q1 | 1.29 Million MYR | 0.0% |
2022 FY | -5.66 Million MYR | -493.88% |
2022 Q4 | -15.86 Million MYR | -597.74% |
2022 Q3 | 3.18 Million MYR | 47.55% |
2021 FY | 1.43 Million MYR | 145.8% |
2020 FY | -3.13 Million MYR | -482648.15% |
2019 FY | -650.00 MYR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
QES Group Berhad | 26.64 Million MYR | 107.077% |
Optimax Holdings Berhad | 21.24 Million MYR | 108.878% |
Pharmaniaga Berhad | 694 Thousand MYR | 371.758% |
Apex Healthcare Berhad | 87.47 Million MYR | 102.156% |